AMGN
Amgen Inc
NASDAQ: AMGN · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$346.25
+2.43% today
Updated 2026-04-30
Market cap
$182.22B
P/E ratio
23.75
P/S ratio
4.96x
EPS (TTM)
$14.23
Dividend yield
2.80%
52W range
$253 – $391
Volume
2.6M
Amgen Inc (AMGN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+13.4%
Last 4 quarters
Revenue YoY growth
+8.9%
Most recent quarter
EPS YoY growth
-0.4%
Most recent quarter
When is the next earnings report?
Reporting date
March 31, 2026
Consensus EPS estimate
$5.16
Fiscal period ending
2026-03-31
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-2.2%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-5.7%
2025-08-05
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-02 | $5.29 | +12.1% | $341.88 | $338.59 | -1.0% |
| 2025-10-29 | $5.64 | +12.4% | $292.09 | $292.00 | -0.0% |
| 2025-08-05 | $6.02 | +14.0% | $301.94 | $284.67 | -5.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $5.16 | — | — | — | — |
| 2025-12-31 | $4.72 | $5.29 | +12.1% | $9.90B | +8.9% |
| 2025-09-30 | $5.02 | $5.64 | +12.4% | $9.56B | +12.4% |
| 2025-06-30 | $5.28 | $6.02 | +14.0% | $9.17B | +9.3% |
| 2025-03-31 | $4.26 | $4.90 | +15.0% | $8.15B | +9.4% |
| 2024-12-31 | $5.08 | $5.31 | +4.5% | $9.09B | +10.9% |
| 2024-09-30 | $5.11 | $5.58 | +9.2% | $8.50B | +23.2% |
| 2024-06-30 | $5.01 | $4.97 | -0.8% | $8.39B | — |
| 2024-03-31 | $3.87 | $3.96 | +2.3% | $7.45B | — |
| 2023-12-31 | $4.61 | $4.71 | +2.2% | $8.20B | — |
| 2023-09-30 | $4.67 | $4.96 | +6.2% | $6.90B | — |
Analyst EPS and revenue estimates for upcoming years
| Period | EPS estimate | Revenue estimate | Revenue growth | Analysts | Confidence |
|---|---|---|---|---|---|
| 2026 (E) | $22.82 | $38.6B | +5.0% | 19 | high |
| 2027 (E) | $23.73 | $39.5B | +2.5% | 19 | medium |
| 2028 (E) | $25.50 | $41.2B | +4.2% | 19 | medium |
| 2029 (E) | $27.08 | $43.8B | +6.3% | 19 | medium |
| 2030 (E) | $29.42 | $46.9B | +7.1% | 19 | low |
Frequently asked questions
When does Amgen Inc report next earnings?
Amgen Inc (AMGN) is scheduled to report earnings on March 31, 2026. The consensus EPS estimate is $5.16.
Has Amgen Inc beaten earnings estimates?
Amgen Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +13.4% over the last 4 quarters.
How does AMGN stock react to earnings?
AMGN stock has moved an average of -2.2% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.
What is Amgen Inc's revenue growth rate?
Amgen Inc reported year-over-year revenue growth of +8.9% in its most recent quarter, with EPS growing -0.4% year-over-year.
What is the expected EPS for AMGN in 2026?
Analysts expect Amgen Inc to report EPS of $22.82 for fiscal year 2026, on revenue of $38.6B, based on estimates from 19 analysts.